This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.


Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


User:Yuan-Ping Pang/Sandbox 1

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
(New page: This is a test.)
Line 1: Line 1:
-
This is a test.
+
'''Model: Botulinum Neurotoxin Serotype A Endopeptidase Liganded with a Nanomolar Small-Molecule Inhibitor HAB - by YP Pang'''
 +
 
 +
----
 +
 
 +
Botulinum neurotoxin serotype A (BoNTA) causes a life-threatening neuroparalytic disease known as botulism. Small-molecule inhibitors of BoNTA endopeptidase (BoNTAe) are sought in our laboratories as antidotes to antagonize the extracellular or intracellular toxin [refs]. HAB is one such inhibitor that exhibits nanomolar potency in inhibiting BoNTAe (to be published). Multiple molecular dynamics simulations of HAB•BoNTAe (20 10-ns-long simulations) suggest that one functional group is highly flexible; the percentages of the top three most-populated conformations of the complex (models 1-3) are 20.8%, 13.4% and 11.9%, respectively. The coordinates of the three models are released before the forthcoming crystal structure of HAB•BoNTAe. Only 60% of the heavy atoms of HAB are released in the models below. The full structure of HAB will be released upon manuscript acceptance.

Revision as of 19:19, 9 March 2010

Model: Botulinum Neurotoxin Serotype A Endopeptidase Liganded with a Nanomolar Small-Molecule Inhibitor HAB - by YP Pang


Botulinum neurotoxin serotype A (BoNTA) causes a life-threatening neuroparalytic disease known as botulism. Small-molecule inhibitors of BoNTA endopeptidase (BoNTAe) are sought in our laboratories as antidotes to antagonize the extracellular or intracellular toxin [refs]. HAB is one such inhibitor that exhibits nanomolar potency in inhibiting BoNTAe (to be published). Multiple molecular dynamics simulations of HAB•BoNTAe (20 10-ns-long simulations) suggest that one functional group is highly flexible; the percentages of the top three most-populated conformations of the complex (models 1-3) are 20.8%, 13.4% and 11.9%, respectively. The coordinates of the three models are released before the forthcoming crystal structure of HAB•BoNTAe. Only 60% of the heavy atoms of HAB are released in the models below. The full structure of HAB will be released upon manuscript acceptance.

Proteopedia Page Contributors and Editors (what is this?)

Yuan-Ping Pang

Personal tools